References
- Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/https://doi.org/10.1016/j.softx.2015.06.001
- Agostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., Ray, A. S., Cihlar, T., Siegel, D., Mackman, R. L., Clarke, M. O., Baric, R. S., & Denison, M. R. (2018). Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio, 9(2), e00221. https://doi.org/https://doi.org/10.1128/mBio.00221-18
- Alobid, I., Bernal, M., Calvo, C., Vilaseca, I., Berenguer, J., & Alós, L. (2001). Treatment of rhinocerebral mucormycosis by combination of endoscopic sinus debridement and amphotericin B. American Journal of Rhinology, 15(5), 327–331. https://doi.org/https://doi.org/10.1177/194589240101500508
- Amarelle, L., & Lecuona, E. (2018). The antiviral effects of Na, K-ATPase inhibition: A minireview. International Journal of Molecular Sciences, 19(8), 2154. https://doi.org/https://doi.org/10.3390/ijms19082154
- Arase, Y., Ikeda, K., Murashima, N., Chayama, K., Tsubota, A., Koida, I., Suzuki, Y., Saitoh, S., Kobayashi, M., & Kumada, H. (1997). The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer, 79(8), 1494–1500. https://doi.org/https://doi.org/10.1002/(sici)1097-0142(19970415)79:8 < 1494::aid-cncr8 > 3.0.co;2-b
- Athanasios, T., Psychos, C., & Domenikos, S. (2020). Communication: Novel drug combination Doxycycline-Melatonin-Digoxin (D-M-D) for possible Covid-19 treatment. Journal of Modern Medicinal Chemistry, 8(1), 1–3. https://doi.org/https://doi.org/10.12970/2308-8044.2020.08.01
- Baba, M., & Shigeta, S. (1987). Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro. Antiviral Research, 7(2), 99–107. https://doi.org/https://doi.org/10.1016/0166-3542(87)90025-8
- Bussi, G., Donadio, D., & Parrinello, M. (2007). Canonical sampling through velocity rescaling. The Journal of Chemical Physics, 126(1), 014101. https://doi.org/https://doi.org/10.1063/1.2408420
- Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020). The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research, 178, 104787. https://doi.org/https://doi.org/10.1016/j.antiviral.2020.104787
- Chang, Y., Tung, Y., Lee, K., Chen, T., Hsiao, Y. , Chang, H. , Hsieh, T., Su, C., Wang, S., Yu, J., Shih, S., Lin, Y., Lin, Y., Tu, Y.E., Hsu, C., Juan, H., Tung, C., Chen, C. Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking. Preprints 2020, 2020020242 (doi: https://doi.org/10.20944/preprints202002.0242.v2).
- Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., & Doerr, H. (2003). Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. The Lancet, 361(9374), 2045–2046. https://doi.org/https://doi.org/10.1016/S0140-6736(03)13615-X
- Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅ log (N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/https://doi.org/10.1063/1.464397
- de Oliveira, O. V., Rocha, G. B., Paluch, A. S., & Costa, L. T. (2020). Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1772885. ISSN: 0739-1102 (Print) 1538-0254 (Online)
- DeLano, W. L. (2002). Pymol: An open-source molecular graphics tool. CCP4 Newsletter on Protein Crystallography, 40, 82–92.
- Elfiky, A. A. (2020a). Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sciences, 248, 117477. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117477
- Elfiky, A. A. (2020b). Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sciences, 253, 117592. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117592
- Feng, C., Wang, H., Yao, C., Zhang, J., & Tian, Z. (2007). Diammonium glycyrrhizinate, a component of traditional Chinese medicine Gan-Cao, prevents murine T-cell-mediated fulminant hepatitis in IL-10-and IL-6-dependent manners. International Immunopharmacology, 7(10), 1292–1298. https://doi.org/https://doi.org/10.1016/j.intimp.2007.05.011
- Götz, V., Magar, L., Dornfeld, D., Giese, S., Pohlmann, A., Höper, D., Kong, B. W., Jans, D. A., Beer, M., Haller, O., & Schwemmle, M. (2016). Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import. Scientific Reports, 6(1 ), 23138–15. https://doi.org/https://doi.org/10.1038/srep23138
- Hackett, A. J., Sylvester, S., Joss, U. R., & Calvin, M. (1972). Synergistic effect of rifamycin derivatives and amphotericin B on viral transformation of a murine cell line. Proceedings of the National Academy of Sciences, 69(12), 3653–3654. https://doi.org/https://doi.org/10.1073/pnas.69.12.3653
- Hess, B., Bekker, H., Berendsen, H. J., & Fraaije, J. G. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/https://doi.org/10.1002/(SICI)1096-987X(199709)18:12 < 1463::AID-JCC4 > 3.0.CO;2-H
- Ito, M., Sato, A., Hirabayashi, K., Tanabe, F., Shigeta, S., Baba, M., De Clercq, E., Nakashima, H., & Yamamoto, N. (1988). Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). Antiviral Research, 10(6), 289–298. https://doi.org/https://doi.org/10.1016/0166-3542(88)90047-2
- Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You,T., Liu, X.,.. . . Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. doi:https://doi.org/10.1038/s41586-020-2223-y
- Kalhor, H., Rahimi, H., Akbari Eidgahi, M. R., & Teimoori-Toolabi, L. (2020). Novel small molecules against two binding sites of Wnt2 protein as potential drug candidates for colorectal cancer: A structure based virtual screening approach. Iranian Journal of Pharmaceutical Research, 19(2), 160–174. https://doi.org/https://doi.org/10.22037/IJPR.2019.15297.13037
- Kalhor, H., Sadeghi, S., Marashiyan, M., Kalhor, R., Aghaei Gharehbolagh, S., Akbari Eidgahi, M. R., & Rahimi, H. (2020). Identification of new DNA gyrase inhibitors based on bioactive compounds from streptomyces: Structure-based virtual screening and molecular dynamics simulations approaches. Journal of Biomolecular Structure & Dynamics, 38(3), 791–806. https://doi.org/https://doi.org/10.1080/07391102.2019.1588784
- Kandeel, M., & Al-Nazawi, M. (2020). Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sciences, 251, 117627. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117627
- Koes, D. R., Baumgartner, M. P., & Camacho, C. J. (2013). Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. Journal of Chemical Information and Modeling, 53(8), 1893–1904. https://doi.org/https://doi.org/10.1021/ci300604z
- Kumari, R., Kumar, R., Consortium, O. S. D. D., & Lynn, A. (2014). g_mmpbsa— A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/https://doi.org/10.1021/ci500020m
- Laskowski, R. A. (2009). PDBsum new things. Nucleic Acids Research, 37(suppl_1), D355–D359. https://doi.org/https://doi.org/10.1093/nar/gkn860
- Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand–protein interaction diagrams for drug discovery. ACS Publications. https://doi.org/https://doi.org/10.1021/ci200227u
- Li, J., Kim, S. G., & Blenis, J. (2014). Rapamycin: One drug, many effects. Cell Metabolism, 19(3), 373–379. https://doi.org/https://doi.org/10.1016/j.cmet.2014.01.001
- Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005). Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science (New York, N.Y.), 309(5742), 1864–1868. https://doi.org/https://doi.org/10.1126/science.1116480
- Lin, J.-C. (2003). Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antiviral Research, 59(1), 41–47. (03)00030-5 https://doi.org/https://doi.org/10.1016/S0166-3542(03)00030-5
- Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4–17. https://doi.org/https://doi.org/10.1016/S0169-409X(00)00129-0
- Lundberg, L., Pinkham, C., Baer, A., Amaya, M., Narayanan, A., Wagstaff, K. M., Jans, D. A., & Kehn-Hall, K. (2013). Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication. Antiviral Research, 100(3), 662–672. https://doi.org/https://doi.org/10.1016/j.antiviral.2013.10.004
- Mohammadi, K., Kometiani, P., Xie, Z., & Askari, A. (2001). Role of protein kinase C in the signal pathways that link Na+/K+-ATPase to ERK1/2. Journal of Biological Chemistry, 276(45), 42050–42056. https://doi.org/https://doi.org/10.1074/jbc.M107892200
- Morgenstern, B., Michaelis, M., Baer, P. C., Doerr, H. W., & Cinatl, J. (2005). Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. Biochemical and Biophysical Research Communications, 326(4), 905–908. https://doi.org/https://doi.org/10.1016/j.bbrc.2004.11.128
- Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/https://doi.org/10.1002/jcc.21256
- Mukhtar, F., & Mukhtar, N. (2020). Coronavirus (COVID-19): Let’s prevent not panic. Journal of Ayub Medical College Abbottabad, 32(1), 141–144.
- Numazaki, K., Nagata, N., Sato, T., & Chiba, S. (1994). Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor α on infection of U‐937 and MRC‐5 cells by human cytomegalovirus. Journal of Leukocyte Biology, 55(1), 24–28. https://doi.org/https://doi.org/10.1002/jlb.55.1.24
- O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(1), 33. https://doi.org/https://doi.org/10.1021/ci200227u
- Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190. https://doi.org/https://doi.org/10.1063/1.328693
- Pollard, H. B., Pollard, B. S., & Pollard, J. R. (2020). Classical drug digitoxin inhibits influenza cytokine storm, with implications for COVID-19 therapy. bioRxiv. https://doi.org/https://doi.org/10.1101/2020.04.09.034983
- Rismanbaf, A. (2020). Potential treatments for COVID-19; a narrative literature review. Archives of Academic Emergency Medicine, 8(1), e29.
- Roggo, S. (2007). Natural products in drug discovery. CHIMIA International Journal for Chemistry, 61(6), 312–312. https://doi.org/https://doi.org/10.2533/chimia.2007.312
- Sander, T., Freyss, J., von Korff, M., & Rufener, C. (2015). DataWarrior: An open-source program for chemistry aware data visualization and analysis. Journal of Chemical Information and Modeling, 55(2), 460–473. https://doi.org/https://doi.org/10.1021/ci500588j
- Sato, H., Goto, W., Yamamura, J., Kurokawa, M., Kageyama, S., Takahara, T., Watanabe, A., & Shiraki, K. (1996). Therapeutic basis of glycyrrhizin on chronic hepatitis B. Antiviral Research, 30(2-3), 171–177. https://doi.org/https://doi.org/10.1016/0166-3542(96)00942-4
- Schüttelkopf, A. W., & Van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein–ligand complexes. Acta Crystallographica Section D Biological Crystallography, 60(8), 1355–1363. https://doi.org/https://doi.org/10.1107/S0907444904011679
- Sekhar, T. (2020). Virtual screening based prediction of potential drugs for COVID-19. Preprints.org. https://doi.org/https://doi.org/10.20944/preprints202002.0418.v2
- Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020). Structural basis of receptor recognition by SARS-CoV-2. Nature, 581(7807), 221–224. https://doi.org/https://doi.org/10.1038/s41586-020-2179-y
- Shanmugaraj, B., Malla, A., & Phoolcharoen, W. (2020). Emergence of novel coronavirus 2019-nCoV: Need for rapid vaccine and biologics development. Pathogens, 9(2), 148. https://doi.org/https://doi.org/10.3390/pathogens9020148
- Shayto, R. H., Mrad, R. A., & Sharara, A. I. (2016). Use of rifaximin in gastrointestinal and liver diseases. World Journal of Gastroenterology, 22(29), 6638. https://doi.org/https://doi.org/10.1038/s41421-020-0153-3
- Shiri, F., Pirhadi, S., & Ghasemi, J. B. (2019). Dynamic structure based pharmacophore modeling of the Acetylcholinesterase reveals several potential inhibitors. Journal of Biomolecular Structure & Dynamics, 37(7), 1800–1813. https://doi.org/https://doi.org/10.1080/07391102.2018.1468281
- Shiri, F., Pirhadi, S., & Rahmani, A. (2018). Identification of new potential HIV-1 reverse transcriptase inhibitors by QSAR modeling and structure-based virtual screening. Journal of Receptor and Signal Transduction Research, 38(1), 37–47. https://doi.org/https://doi.org/10.1080/10799893.2017.1414844
- Siddell, S. G., Anderson, R., Cavanagh, D., Fujiwara, K., Klenk, H. D., Macnaughton, M. R., Pensaert, M., Stohlman, S. A., Sturman, L., & van der Zeijst, B. A. (1983). Coronaviridae. Intervirology, 20(4), 181–189. https://doi.org/https://doi.org/10.1159/000149390
- Song, W., Gui, M., Wang, X., & Xiang, Y. (2018). Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLOS Pathogens, 14(8), e1007236. p https://doi.org/https://doi.org/10.1371/journal.ppat.1007236
- Stöhr, S., Costa, R., Sandmann, L., Westhaus, S., Pfaender, S., Anggakusuma, Dazert, E., Meuleman, P., Vondran, F. W. R., Manns, M., Steinmann, E., Hahn, T., & Ciesek, S. (2016). Host cell mTORC1 is required for HCV RNA replication. Gut, 65(12), 2017–2028. https://doi.org/https://doi.org/10.1136/gutjnl-2014-308971
- Tay, M. Y. F., Fraser, J. E., Chan, W. K. K., Moreland, N. J., Rathore, A. P., Wang, C., Vasudevan, S. G., & Jans, D. A. (2013). Nuclear ocalization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENVserotypes by the inhibitor Ivermectin. Antiviral Research, 99(3), 301–306. https://doi.org/https://doi.org/10.1016/j.antiviral.2013.06.002
- Thakur, A., & Raj, P. (2017). Pharmacological perspective of Glycyrrhiza glabra Linn: A mini-review. Journal of Analytical & Pharmaceutical Research, 5(5), 00156. https://doi.org/https://doi.org/10.15406/japlr.2017.05.00156
- Tinku Gupta, M. M. (2018). Ammonium glycyrrhizinate: a compherensive review of its traditionaluse, phytochemistry, pharmacology & safety. Asian Journal of Pharmaceutical Education and Research, 7(1), 58–65.
- Utsunomiya, T., Kobayashi, M., Herndon, D. N., Pollard, R. B., & Suzuki, F. (1995). Glycyrrhizin(20β-carboxy-11-oxo-30-norolean-12-en-3β-yl-2-O-β-d-glucopyranuronosyl-α-d-glucopyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1. Immunology Letters, 44(1), 59–66. https://doi.org/https://doi.org/10.1016/0165-2478(94)00183-R
- Utsunomiya, T., Kobayashi, M., Pollard, R. B., & Suzuki, F. (1997). Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrobial Agents and Chemotherapy, 41(3), 551–556. https://doi.org/https://doi.org/10.1128/AAC.41.3.551
- Van Tilbeurgh, H., Bezzine, S., Cambillau, C., Verger, R., & Carriere, F. (1999). Colipase: Structure and interaction with pancreatic lipase. Biochimica et Biophysica Acta (Bba) - Molecular and Cell Biology of Lipids, 1441(2–3), 173–184. https://doi.org/https://doi.org/10.1016/S1388-1981(99)00149-3
- Visualizer, B. D. S. (2017). Version 4.5 (software). http://mayavi.sourceforge.net
- Wagstaff, K. M., Sivakumaran, H., Heaton, S. M., Harrich, D., & Jans, D. A. (2012). Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. The Biochemical Journal, 443(3), 851–856. https://doi.org/https://doi.org/10.1042/BJ20120150
- Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (New York, N.Y.), 367(6483), 1260–1263. https://doi.org/https://doi.org/10.1126/science.abb2507
- Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., Yuan, M.-L., Zhang, Y.-L., Dai, F.-H., Liu, Y., Wang, Q.-M., Zheng, J.-J., Xu, L., Holmes, E. C., & Zhang, Y.-Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269. https://doi.org/https://doi.org/10.1038/s41586-020-2008-3
- Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. (2020). Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences, 63(3), 457–460. https://doi.org/https://doi.org/10.1007/s11427-020-1637-5
- Yu, X., & Sun, D. (2013). Macrocyclic drugs and synthetic methodologies toward macrocycles. Molecules (Basel, Switzerland), 18(6), 6230–6268. https://doi.org/https://doi.org/10.3390/molecules18066230
- Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020). Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery, 6(1), 14–18. https://doi.org/https://doi.org/10.1038/s41421-020-0153-3
- Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/https://doi.org/10.1056/NEJMoa2001017